Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Qigong Intervention for Fibromyalgia

NCT07830186 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-15
Last updated
2026-09-24

Condition(s) studied

Fibromyalgia

Investigational drug(s) / intervention(s)

Mobility-Intensive Qigong ExerciseStatic Posture-Based Qigong Exercise

Mobility-Intensive Qigong Exercise: Dynamic and fluid mobility-intensive Qigong exercises focusing on active range of motion, muscle flexibility, muscle strengthening, and breath coordination under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

Static Posture-Based Qigong Exercise: Participants receive static posture-based Qigong exercises consisting of sustained isometric postures, breath regulation, and alignment control to enhance postural stability, static endurance, and core strengthening under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

Study summary

This randomized controlled pilot study investigates the comparative efficacy of mobility-intensive Qigong exercises versus static posture-based Qigong exercises in patients diagnosed with fibromyalgia. Participants are randomly allocated to either a mobility-intensive Qigong intervention group or a static posture-based Qigong intervention group. The primary objectives are to evaluate improvements in spinal mobility and reductions in pain levels. Secondary outcomes include enhancements in functional exercise capacity, reductions in fatigue severity, and improvements in health-related quality of life. All outcome assessments are conducted at baseline and upon completion of the intervention program.

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Female patients aged between 30 and 50 years. * Diagnosed with fibromyalgia according to the 2010 American College of Rheumatology (ACR) criteria. * Non-obese, defined as Body Mass Index (BMI) \< 30 kg/m². * Lack of clinical improvement despite receiving pharmacological treatment for more than 3 months. * Willingness to adhere to the 12-week supervised online exercise program. Exclusion Criteria: * Pregnancy or currently breastfeeding. * Presence of advanced musculoskeletal pathologies (e.g., inflammatory arthritis, severe osteoarthritis). * Diagnosed neurological disorders or peripheral neuropathy. * Known severe cardiovascular diseases. * History of surgical intervention within the past 4 months. * Participation in any regular physical exercise or rehabilitation program within the past 2 months prior to enrollment.

Primary outcome measure(s)

  • Change in Pain Intensity Measured by Visual Analog Scale (VAS) — Baseline and post-intervention at Week 12
    Pain intensity is evaluated using a 100-mm Visual Analog Scale (VAS), where 0 mm indicates "no pain" and 100 mm indicates "unbearable pain." Participants mark their perceived pain intensity on a horizontal 100-mm line. Higher scores represent greater pain severity. Changes from baseline to the end of the 12-week intervention are assessed.

Trial sites (1)

FacilityCityRegionStatus
Akdeniz University Hospital, Department of Physical Medicine and Rehabilitation Antalya Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07830186 on ClinicalTrials.gov ↗ ← All trials in Turkey